keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 263.00 | |
5 mg | In stock | $ 689.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,690.00 | |
50 mg | In stock | $ 2,320.00 | |
100 mg | In stock | $ 3,130.00 |
Description | Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity. |
In vitro | Under high glucose-induced conditions, treatment of SHSY5Y cells with Tirzepatide sodium salt at concentrations ranging from 0 to 0.4 μM for 7 days resulted in significant upregulation of CREB and BDNF mRNA expression. Additionally, it increased the protein levels of pAkt, MAP2, GAP43, AGBL4, GLUT4, SORBS1, and Bcl-2 while decreasing the protein level of BAX[1]. |
In vivo | In diet-induced obese (DIO) mice, Tirzepatide sodium salt (10 nM/kg, subcutaneous injection) reduced body weight and food consumption. It decreased glucose, insulin, leptin, and C-peptide levels[2]. |
Synonyms | LY-3298176 sodium salt, Tirzepatide sodium salt(2023788-19-2 free base) |
Molecular Weight | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tirzepatide sodium salt GPCR/G Protein Glucagon Receptor LY-3298176 sodium salt Tirzepatide sodium salt(2023788-19-2 free base) inhibitor inhibit